电离辐射:分子机制,生物效应和治疗点
Wei Wei1, Yifan Ren2,1, Jinxin Lan3
1Senior Department of Oncology, Chinese PLA General Hospital, 100853, Beijing, China.
Molecular biomedicine
|January 8, 2026
概括
辐射诱导的伤害对接受放射治疗的癌症患者来说是一个重大挑战. 本综述详细介绍了损伤机制,症状和新兴的治疗方法,如干细胞疗法,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 辐射生物学 辐射生物学
- 分子医学是分子医学.
背景情况:
- 放射治疗是癌症治疗的基石,但电离辐射会导致显著的细胞和分子损伤.
- 辐射诱导损伤 (RII) 导致急性和慢性器官功能障碍,影响患者的生活质量和治疗坚持.
- 了解RII机制对于开发有效的管理策略至关重要.
研究的目的:
- 审查RII在多个器官系统中的分子和细胞机制的最新进展.
- 总结目前对RII的诊断策略,风险因素和临床治疗方法.
- 突出管理RII的新兴治疗方法.
主要方法:
- 关于RII的分子和细胞机制的综合文献综述.
- 分析涉及辐射损伤的信号通路和细胞反应.
- 对RII的临床治疗和新兴疗法的评估.II.
主要成果:
- RII涉及氧化应激,DNA损伤反应,线粒体功能障碍和表观遗传改变.
- 主要受影响的器官包括肺,胃肠道系统,大脑,皮肤和骨.
- 目前的治疗方法存在,有前途的新兴疗法,如干细胞疗法,纳米医学和外体.
结论:
- 在理解RII机制方面取得了重大进展.
- 将分子洞察力转化为有效的疗法仍然是一个挑战.
- 需要综合,精准医学方法来改善RII管理和患者的治疗结果.
相关概念视频
Biological Effects of Radiation
17.6K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
17.6K
Mutations
42.7K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
42.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K


